Bernard D.
- Country
- Spain
- Department
- Oncology
Research Overview
- Phase I Clinical Trial of TOS-358 in Adult Patients with Advanced Solid Tumors: Colorectal, Cervical, Endometrial, Gastric, Urothelial, Breast, Head and Neck, Ovarian, and NSCLC.
- Evaluation of Safety, Tolerability, Dosimetry, and Preliminary Activity of [177Lu]Lu-NNS309 in Advanced Unresectable or Metastatic NSCLC, BC, PDAC, and CRC.
- Evaluation of ABX-001 Monotherapy and in Combination with Pembrolizumab in Patients with Advanced Solid Tumors Beyond Standard of Care
Data & Insights
Has run more than one trial at 134 of 229 partner sites.
Specializations
Solid Tumor Research
The investigator specializes in clinical research involving advanced solid tumors, with particular emphasis on novel therapeutic approaches and combination treatments.
- Metastatic cancers
- Locally advanced tumors
- Novel immunotherapy combinations
Studies focus on evaluating experimental treatments across multiple tumor types.
Targeted Cancer Therapy
Expertise in precision oncology approaches targeting specific molecular pathways and genetic mutations.
- KRAS mutations
- HER2-positive cancers
- Receptor-targeted therapies
Investigates novel drug combinations and targeted therapeutic strategies.
Specialty Cancer Areas
Focused research in specific cancer types requiring specialized therapeutic approaches.
- Lung cancer
- Breast cancer
- Gastrointestinal cancers
- Gynecologic malignancies
Conducts trials across multiple cancer indications with innovative treatment modalities.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.